Orchestra BioMed (OBIO) Misses Q2 EPS by 50c
Orchestra BioMed (NASDAQ: OBIO) reported Q2 EPS of ($0.50). Revenue for the quarter came in at $840 thousand.
For earnings history and earnings-related data on Orchestra BioMed (OBIO) click here.
Orchestra BioMed (NASDAQ: OBIO) reported Q2 EPS of ($0.50). Revenue for the quarter came in at $840 thousand.
For earnings history and earnings-related data on Orchestra BioMed (OBIO) click here.